Atrial Tachyarrhythmia Prevalence in Patients with Implantable Cardiac Resynchronization Defibrillators

Shane Gillett; Chris Reyes; David T. Martin; Professor Gregory Lip

doi:10.1016/j.cardfail.2018.07.257

Related publications

Article2023

Ventricular arrhythmias and cardiac arrest in atrial fibrillation patients with pacemakers and implantable cardioverter-defibrillators

Ameenathul M. Fawzy, Arnaud Bisson, Sid Ahmed Bentounes, Alexandre Bodin, Julien Herbert, Professor Gregory Lip, Laurent Fauchier

Article2025

Clinical Phenotypes in Relation to Outcomes in Heart Failure Patients With Cardiac Resynchronization Therapy and Defibrillators (CRT‐D): An Unsupervised Cluster Analysis

Luigi Gerra, Tommaso Bucci, Arnaud Bisson, Alexandre Bodin, Bertrand Pierre, Giuseppe Boriani, Professor Gregory Lip, Laurent Fauchier

Article2024

Long-term outcomes associated with subcutaneous implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy

Valeria Rella, N Maurizi, Andrea Bernardini, Francesco Brasca, S. Salerno, Manjula Meda, Diana Mariani, Margherita Torchio, Giulio Conte, A Auricchio, Gianfranco Parati, Iacopo Olivotto, Giovanni Battista Perego, Franco Cecchi, Lia Crotti

Article2023

Risk of Atrial Fibrillation and Adverse Outcomes in Patients With Cardiac Implantable Electronic Devices

So-Ryoung Lee, Ji Hyun Lee, Eue-Keun Choi, Eun‐Kyung Jung, So-Jeong You, Seil Oh, Professor Gregory Lip

Article2008

Post-Discharge Adjudicated Outcomes in Patients with Implantable Cardioverter-Defibrillators in the EVEREST Trial

Norman C. Wang, Marvin A. Konstam, Aldo Maggioni, Brian Traver, John C. Burnett, Liliana Grinfeld, Karl Swedberg, James E. Udelson, Faı̈ez Zannad, Thomas D. Cook, Christopher Zimmer, O'Connor Christopher, Alan B. Miller, Mihai Gheorghiade, The Everest Investigators